Damora Therapeutics (DMRA) Change in Acquisitions & Divestments (2021 - 2024)

Damora Therapeutics (DMRA) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $6.0 million in Q2 2024.

• For the quarter ending Q2 2024, Change in Acquisitions & Divestments fell 51.35% year-over-year to $6.0 million; the trailing twelve-month figure through Dec 2024 stood at $11.6 million (down 75.82% YoY), and the FY2024 full-year result was $11.6 million, down 75.82% from the prior year.
• Change in Acquisitions & Divestments for Q2 2024 stood at $6.0 million, up from $5.6 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $18.6 million in Q4 2022 and bottomed at $5.6 million in Q1 2024.
• The 4-year median for Change in Acquisitions & Divestments is $12.3 million (2023), against an average of $11.8 million.
• The widest annual swing landed in 2023, when Change in Acquisitions & Divestments jumped 44.71%; it then tumbled 60.0% in 2024.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $14.4 million in 2021, then rose by 28.96% to $18.6 million in 2022, then tumbled by 48.89% to $9.5 million in 2023, then tumbled by 36.82% to $6.0 million in 2024.
• The last three Change in Acquisitions & Divestments figures came in at $6.0 million (Q2 2024), $5.6 million (Q1 2024), and $9.5 million (Q4 2023), per Business Quant data.

Peer Comparison